Navigation Links
Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Date:11/19/2007

well as a license from Alnylam. The Company has licensed RTP801i-14 to Pfizer on an exclusive worldwide basis. Quark has, in addition, a product candidate portfolio of RNAi therapeutics based on novel targets and therapeutic concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs of the body.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at http://www.quarkpharma.com

Quark Pharmaceuticals, Inc.

Gavin Samuels

(510) 449 6737

GSamuels@quarkpharma.com

The Ruth Group

Stephanie Carrington / Elizabeth Scott (investors)

(646) 536-7017 / 7014

scarrington@theruthgroup.com

escott@theruthgroup.com

Janine McCargo (media)

(646) 536-7033

jmccargo@theruthgroup.com


'/>"/>
SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Calif. , April 30, 2015  Accuray ... it has signed an agreement with MIM Software ... the TomoTherapy ® and CyberKnife ® product ... Accuray and MIM technology. This is Accuray,s second ... the development of the first iPad-based treatment plan ...
(Date:4/30/2015)... April 30, 2015  Thoratec Corporation (NASDAQ: THOR ... to save, support and restore failing hearts, said today ... Lynch 2015 Healthcare Conference on Thursday, May 14. ... Executive Officer, will provide an update on the company, ... Eastern Daylight Time). The presentation will be ...
(Date:4/30/2015)... Calif., April 30, 2015  DURECT Corporation (Nasdaq: ... quarter of 2015.  Total revenues were $4.8 million and ... ended March 31, 2015 as compared to total revenues ... for the three months ended March 31, 2014.At March ... million, compared to cash and investments of $34.9 million ...
Breaking Medicine Technology:Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9
... 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Application (NDA) to the U.S. Food and Drug Administration (FDA) ... October 2010.  The Company believes this is a Class 2 ... for the rapid treatment of agitation in schizophrenia or bipolar ...
... For manufacturers who must comply with current Good Manufacturing ... be time consuming and difficult. This task is considerably ... each with their own GMP requirements. PharmOut, ... an online database of GMP guidelines. This database, available ...
Cached Medicine Technology:Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA 2Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA 3Global GMP Guidelines Available in Online GMP Library 2
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious ... its flagship nutritional supplement, Liquid BioCell™ Life, and the ... new logo, new packaging, new products, and new messaging. ... identify and promote programs that serve as examples of ... Jusuru International for their outstanding accomplishments and contributions to ...
(Date:5/1/2015)... 01, 2015 The Workgroup for ... authority on the use of health IT to create ... contributing resource to the United States Government Accountability Office ... readable cards in Medicare. The report, “ Potential Uses ... was released to the public on Apr. 24, 2015 ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in both ... for telemedicine. , “Such action is unprecedented in ... said Jonathan Linkous, CEO of the American Telemedicine Association (ATA). ... embrace the use of telecommunications in the delivery of care. ... to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... Ernst & Young (EY) has announced Melanie Rosenthal, ... and Burak Sezen, Co-Founder & CTO of RowdMap, Inc. ... The Year® 2015 Awards in the Ohio Valley Region ... leader in assurance, tax, transaction and advisory services and ... audit companies in the world. The awards program recognizes ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... shows screening newborns for biochemical genetic disorders may improve ... researchers say false-positive screening results may increase stress levels ... required a separate test, but now, doctors can screen ... sample of blood by using a device called the ...
... is a joyous experience. But if the experience does not ... the woman. Researchers conducted a study to obtain the views ... the second stage of labor. ,A new study ... the delivery of their child may happen. Researchers say women ...
... women who change partners between the births of their first two ... birth weight than women who have the same partner.// ... the first year of life. The results are the same even ... interval between births, and the decades of birth. ...
... announced what it calls the second heart-related death in ... for a government //investigation into the safety of that ... ,The Physicians Committee for Responsible Medicine states that a ... cardiac arrest while on the Atkins diet. The group ...
... study shows a novel new drug is beneficial for ... and is the first in a new class of ... drug is called cytotoxic T-lymphocyte-associated antigen 4-IgG1 or CTLA4Ig. ... treatment of rheumatoid arthritis. Researchers from Belgium conducted a ...
... It's called partial-breast irradiation, and proponents see it as ... just had a lumpectomy.// ,Thousands of women ... one week or less of radiation after breast cancer ... required for whole-breast irradiation. ,But its long-term benefits ...
Cached Medicine News:Health News:Screening Newborns Questioned 2Health News:Changing Partners may put Expectant Mothers at Risk 2Health News:Partial-Breast Irradiation an Unproven Therapy 2
... 1000 Power Instrument System is a small ... with modular and unitized handpieces.,The head modules ... or pneumatic motor, giving you the flexibility ... the motor. Now you can add instruments ...
... large power line from MicroAire. Our ... AND electric instruments, offering the ultimate ... industry has always wanted with the ... Power Master oscillating saw, Available ...
... Oscillating Saw offers unparalleled power ... to its 14.4V NiMH Rechargeable ... may be rotated into 12 ... plane and will accept any ...
... The SmartDriver System consists of a ... Battery Power, with a wide range of ... variety of orthopedic surgical applications., ,The ... and speed compared to the original Battery ...
Medicine Products: